Continuation treatment of major depressive disorder: is there a case for duloxetine?
Trevor R Norman, James S Olver
Drug Design, Development and Therapy | DOVE MEDICAL PRESS LTD | Published : 2010
Trevor R Norman has served on advisory boards and/or received support for travel, talks or research from Astra-Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli-Lilly, Janssen, Lundbeck, Organon, Pfizer, Servier, and Wyeth in the past five years. James S Olver has received educational and research grants from Astra-Zeneca, Eli-Lilly, and Janssen in the past five years.